Report Detail

Request for Sample of this report

Other Global Cancer (Tumor) Profiling Market 2024 by Company, Regions, Type and Application, Forecast to 2030

  • RnM4598911
    • |
  • 02 July, 2024
    • |
  • Global
    • |
  • 117 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Other

According to our (Global Info Research) latest study, the global Cancer (Tumor) Profiling market size was valued at USD 9533.2 million in 2023 and is forecast to a readjusted size of USD 19440 million by 2030 with a CAGR of 10.7% during review period.
Cancer(tumor) profiling is the technology oncologists use to determine if the pathways of a patient's tumor match up with available targeted treatments. Tumor profiling starts with obtaining a sample of tumor tissue. The tissue is usually collected through a core biopsy, but it can also be taken during surgery.
Surging cancer prevalence across the globe is one of the major factors contributing to the market growth. Cancer is the second leading cause of death worldwide. One in six deaths worldwide is due to cancer. In middle- and lower-class economies, 70% of deaths are due to cancer. This expands the growth scope of the market. Surging public-private funding of targeted research activities, emergence of cancer profiling relative to traditional methods of cancer diagnosis, increasing geriatric population base, and increasing product innovation and development due to technological advancements across the world will provide lucrative opportunities for market players. Estimated period 2022-2029. In addition, the surge in the number of strategic cooperations, rising Internet penetration, increasing number of hospitals and laboratories, increasing cases of lung cancer, prostate cancer, and acute leukemia, and increasing healthcare expenditure per capita will lead to further expansion of the market growth rate in the future.
The Global Info Research report includes an overview of the development of the Cancer (Tumor) Profiling industry chain, the market status of Clinical (Immunoassay, NGS), Research (Immunoassay, NGS), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Cancer (Tumor) Profiling.
Regionally, the report analyzes the Cancer (Tumor) Profiling markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Cancer (Tumor) Profiling market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Cancer (Tumor) Profiling market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Cancer (Tumor) Profiling industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Immunoassay, NGS).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Cancer (Tumor) Profiling market.
Regional Analysis: The report involves examining the Cancer (Tumor) Profiling market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Cancer (Tumor) Profiling market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Cancer (Tumor) Profiling:
Company Analysis: Report covers individual Cancer (Tumor) Profiling players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Cancer (Tumor) Profiling This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Clinical, Research).
Technology Analysis: Report covers specific technologies relevant to Cancer (Tumor) Profiling. It assesses the current state, advancements, and potential future developments in Cancer (Tumor) Profiling areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Cancer (Tumor) Profiling market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Cancer (Tumor) Profiling market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Immunoassay
NGS
Mass Spectrometry
Others
Market segment by Application
Clinical
Research
Market segment by players, this report covers
Illumina
Qiagen
Neogenomics Laboratories
HTG Molecular Diagnostics
Genomic Health
Caris Life Sciences
Helomics Corporation
Nanostring Technologies
Oxford Gene Technology
Ribomed Biotechnologies
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Cancer (Tumor) Profiling product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Cancer (Tumor) Profiling, with revenue, gross margin and global market share of Cancer (Tumor) Profiling from 2019 to 2024.
Chapter 3, the Cancer (Tumor) Profiling competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Cancer (Tumor) Profiling market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Cancer (Tumor) Profiling.
Chapter 13, to describe Cancer (Tumor) Profiling research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Cancer (Tumor) Profiling
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Cancer (Tumor) Profiling by Type
    • 1.3.1 Overview: Global Cancer (Tumor) Profiling Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global Cancer (Tumor) Profiling Consumption Value Market Share by Type in 2023
    • 1.3.3 Immunoassay
    • 1.3.4 NGS
    • 1.3.5 Mass Spectrometry
    • 1.3.6 Others
  • 1.4 Global Cancer (Tumor) Profiling Market by Application
    • 1.4.1 Overview: Global Cancer (Tumor) Profiling Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Clinical
    • 1.4.3 Research
  • 1.5 Global Cancer (Tumor) Profiling Market Size & Forecast
  • 1.6 Global Cancer (Tumor) Profiling Market Size and Forecast by Region
    • 1.6.1 Global Cancer (Tumor) Profiling Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global Cancer (Tumor) Profiling Market Size by Region, (2019-2030)
    • 1.6.3 North America Cancer (Tumor) Profiling Market Size and Prospect (2019-2030)
    • 1.6.4 Europe Cancer (Tumor) Profiling Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific Cancer (Tumor) Profiling Market Size and Prospect (2019-2030)
    • 1.6.6 South America Cancer (Tumor) Profiling Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East and Africa Cancer (Tumor) Profiling Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 Illumina
    • 2.1.1 Illumina Details
    • 2.1.2 Illumina Major Business
    • 2.1.3 Illumina Cancer (Tumor) Profiling Product and Solutions
    • 2.1.4 Illumina Cancer (Tumor) Profiling Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Illumina Recent Developments and Future Plans
  • 2.2 Qiagen
    • 2.2.1 Qiagen Details
    • 2.2.2 Qiagen Major Business
    • 2.2.3 Qiagen Cancer (Tumor) Profiling Product and Solutions
    • 2.2.4 Qiagen Cancer (Tumor) Profiling Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Qiagen Recent Developments and Future Plans
  • 2.3 Neogenomics Laboratories
    • 2.3.1 Neogenomics Laboratories Details
    • 2.3.2 Neogenomics Laboratories Major Business
    • 2.3.3 Neogenomics Laboratories Cancer (Tumor) Profiling Product and Solutions
    • 2.3.4 Neogenomics Laboratories Cancer (Tumor) Profiling Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Neogenomics Laboratories Recent Developments and Future Plans
  • 2.4 HTG Molecular Diagnostics
    • 2.4.1 HTG Molecular Diagnostics Details
    • 2.4.2 HTG Molecular Diagnostics Major Business
    • 2.4.3 HTG Molecular Diagnostics Cancer (Tumor) Profiling Product and Solutions
    • 2.4.4 HTG Molecular Diagnostics Cancer (Tumor) Profiling Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 HTG Molecular Diagnostics Recent Developments and Future Plans
  • 2.5 Genomic Health
    • 2.5.1 Genomic Health Details
    • 2.5.2 Genomic Health Major Business
    • 2.5.3 Genomic Health Cancer (Tumor) Profiling Product and Solutions
    • 2.5.4 Genomic Health Cancer (Tumor) Profiling Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Genomic Health Recent Developments and Future Plans
  • 2.6 Caris Life Sciences
    • 2.6.1 Caris Life Sciences Details
    • 2.6.2 Caris Life Sciences Major Business
    • 2.6.3 Caris Life Sciences Cancer (Tumor) Profiling Product and Solutions
    • 2.6.4 Caris Life Sciences Cancer (Tumor) Profiling Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Caris Life Sciences Recent Developments and Future Plans
  • 2.7 Helomics Corporation
    • 2.7.1 Helomics Corporation Details
    • 2.7.2 Helomics Corporation Major Business
    • 2.7.3 Helomics Corporation Cancer (Tumor) Profiling Product and Solutions
    • 2.7.4 Helomics Corporation Cancer (Tumor) Profiling Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Helomics Corporation Recent Developments and Future Plans
  • 2.8 Nanostring Technologies
    • 2.8.1 Nanostring Technologies Details
    • 2.8.2 Nanostring Technologies Major Business
    • 2.8.3 Nanostring Technologies Cancer (Tumor) Profiling Product and Solutions
    • 2.8.4 Nanostring Technologies Cancer (Tumor) Profiling Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Nanostring Technologies Recent Developments and Future Plans
  • 2.9 Oxford Gene Technology
    • 2.9.1 Oxford Gene Technology Details
    • 2.9.2 Oxford Gene Technology Major Business
    • 2.9.3 Oxford Gene Technology Cancer (Tumor) Profiling Product and Solutions
    • 2.9.4 Oxford Gene Technology Cancer (Tumor) Profiling Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Oxford Gene Technology Recent Developments and Future Plans
  • 2.10 Ribomed Biotechnologies
    • 2.10.1 Ribomed Biotechnologies Details
    • 2.10.2 Ribomed Biotechnologies Major Business
    • 2.10.3 Ribomed Biotechnologies Cancer (Tumor) Profiling Product and Solutions
    • 2.10.4 Ribomed Biotechnologies Cancer (Tumor) Profiling Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Ribomed Biotechnologies Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Cancer (Tumor) Profiling Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of Cancer (Tumor) Profiling by Company Revenue
    • 3.2.2 Top 3 Cancer (Tumor) Profiling Players Market Share in 2023
    • 3.2.3 Top 6 Cancer (Tumor) Profiling Players Market Share in 2023
  • 3.3 Cancer (Tumor) Profiling Market: Overall Company Footprint Analysis
    • 3.3.1 Cancer (Tumor) Profiling Market: Region Footprint
    • 3.3.2 Cancer (Tumor) Profiling Market: Company Product Type Footprint
    • 3.3.3 Cancer (Tumor) Profiling Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Cancer (Tumor) Profiling Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global Cancer (Tumor) Profiling Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global Cancer (Tumor) Profiling Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global Cancer (Tumor) Profiling Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America Cancer (Tumor) Profiling Consumption Value by Type (2019-2030)
  • 6.2 North America Cancer (Tumor) Profiling Consumption Value by Application (2019-2030)
  • 6.3 North America Cancer (Tumor) Profiling Market Size by Country
    • 6.3.1 North America Cancer (Tumor) Profiling Consumption Value by Country (2019-2030)
    • 6.3.2 United States Cancer (Tumor) Profiling Market Size and Forecast (2019-2030)
    • 6.3.3 Canada Cancer (Tumor) Profiling Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico Cancer (Tumor) Profiling Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe Cancer (Tumor) Profiling Consumption Value by Type (2019-2030)
  • 7.2 Europe Cancer (Tumor) Profiling Consumption Value by Application (2019-2030)
  • 7.3 Europe Cancer (Tumor) Profiling Market Size by Country
    • 7.3.1 Europe Cancer (Tumor) Profiling Consumption Value by Country (2019-2030)
    • 7.3.2 Germany Cancer (Tumor) Profiling Market Size and Forecast (2019-2030)
    • 7.3.3 France Cancer (Tumor) Profiling Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom Cancer (Tumor) Profiling Market Size and Forecast (2019-2030)
    • 7.3.5 Russia Cancer (Tumor) Profiling Market Size and Forecast (2019-2030)
    • 7.3.6 Italy Cancer (Tumor) Profiling Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific Cancer (Tumor) Profiling Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific Cancer (Tumor) Profiling Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific Cancer (Tumor) Profiling Market Size by Region
    • 8.3.1 Asia-Pacific Cancer (Tumor) Profiling Consumption Value by Region (2019-2030)
    • 8.3.2 China Cancer (Tumor) Profiling Market Size and Forecast (2019-2030)
    • 8.3.3 Japan Cancer (Tumor) Profiling Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea Cancer (Tumor) Profiling Market Size and Forecast (2019-2030)
    • 8.3.5 India Cancer (Tumor) Profiling Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia Cancer (Tumor) Profiling Market Size and Forecast (2019-2030)
    • 8.3.7 Australia Cancer (Tumor) Profiling Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America Cancer (Tumor) Profiling Consumption Value by Type (2019-2030)
  • 9.2 South America Cancer (Tumor) Profiling Consumption Value by Application (2019-2030)
  • 9.3 South America Cancer (Tumor) Profiling Market Size by Country
    • 9.3.1 South America Cancer (Tumor) Profiling Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil Cancer (Tumor) Profiling Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina Cancer (Tumor) Profiling Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa Cancer (Tumor) Profiling Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa Cancer (Tumor) Profiling Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa Cancer (Tumor) Profiling Market Size by Country
    • 10.3.1 Middle East & Africa Cancer (Tumor) Profiling Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey Cancer (Tumor) Profiling Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia Cancer (Tumor) Profiling Market Size and Forecast (2019-2030)
    • 10.3.4 UAE Cancer (Tumor) Profiling Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 Cancer (Tumor) Profiling Market Drivers
  • 11.2 Cancer (Tumor) Profiling Market Restraints
  • 11.3 Cancer (Tumor) Profiling Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Cancer (Tumor) Profiling Industry Chain
  • 12.2 Cancer (Tumor) Profiling Upstream Analysis
  • 12.3 Cancer (Tumor) Profiling Midstream Analysis
  • 12.4 Cancer (Tumor) Profiling Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Cancer (Tumor) Profiling. Industry analysis & Market Report on Cancer (Tumor) Profiling is a syndicated market report, published as Global Cancer (Tumor) Profiling Market 2024 by Company, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Cancer (Tumor) Profiling market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,634.36
    		3,951.54
    		5,268.72
    		3,132.00
    		4,698.00
    		6,264.00
    		494,682.00
    		742,023.00
    		989,364.00
    		291,380.40
    		437,070.60
    		582,760.80
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo